Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 19 September at 4:30pm because of system upgrades. We expect to open them again on Friday 20 September at 8am the latest.

Analysis of the Swedish Drug Development Pipeline

Reference number
Coordinator SwedenBIO Service AB
Funding from Vinnova SEK 100 000
Project duration December 2011 - December 2012
Status Completed

Important results from the project

Map the pipeline of Swedish drug development and to visualize the situation of the industry and the need of support. The project aims to improve the visibility of the Swedish life science industry. SwedenBIO will make a web-based survey of the Swedish drug development pipeline based on VINNOVAs, Invest Sweden´s and SwedenBIO:s list of companies. The visibility of Swedish research within drug development is increased both nationally and internationally by this report. The impact in media has been good and the report is an important tool for SwedenBIO, Vinnova and Invest Sweden.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2011-04218